| 3/11/2018 | 300450000000 | VETERINER DRUG (METABOLASE 500-ML)
| 3850 | Units | 16238.81 | AtatUrk Airport Cargo Customs | GÜNESLI ASI ILAÇ ITH.IHR.GIDA ÜRT.SAN.VE TIC. A.S. |
| 3/26/2018 | 300490000000 | MEDICINE (METALCAPTASE)
| 1000 | Units | 46660.83 | N/A | TÜRK ECZACILARI BIRLIGI IKTISADI ISLETMESI |
| 3/11/2018 | 300450000000 | VETERINARY DRUG (METABOLASE 250-ML)
| 5225 | Units | 14904.35 | AtatUrk Airport Cargo Customs | GÜNESLI ASI ILAÇ ITH.IHR.GIDA ÜRT.SAN.VE TIC. A.S. |
| 3/11/2018 | 300450000000 | VETERINER DRUG (METABOLASE 500-ML)
| 2750 | Units | 11600.19 | AtatUrk Airport Cargo Customs | GÜNESLI ASI ILAÇ ITH.IHR.GIDA ÜRT.SAN.VE TIC. A.S. |
| 3/15/2024 | 300214000000 | PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA | 6 | UNIT | 28720 | N/A | ICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ |
| 3/15/2024 | 300214000000 | PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA | 4 | UNIT | 19382 | N/A | ICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ |
| 3/15/2024 | 300214000000 | PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA | 8 | UNIT | 38516 | N/A | ICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ |
| 3/15/2024 | 300214000000 | PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA | 2 | UNIT | 9982 | N/A | ICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ |
| 3/15/2024 | 300214000000 | PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA | 10 | UNIT | 47958 | N/A | ICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ |
| 3/19/2024 | 300214000000 | PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA | 10 | UNIT | 47649 | N/A | ICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ |